Success in today's competitive drug development market requires
low cost, accelerated programs to move new compounds rapidly through
the discovery pipeline. Traditional drug development practices involve costly,
time-consuming clinical studies.
Oncotech's state-of-the-art laboratory offers products and services
that will reduce development costs by improving the lead to market
timeline and increase profitability by extension of product lifecycle.
Through the performance of in vitro and ex vivo studies, Oncotech has
proven its ability to speed identification and validation of lead
compounds and new tumor targets through ex vivo human tumor
studies and sophisticated molecular profiling. Oncotech's theragnostic
screening and monitoring tools are used to drive the development and
implementation of clinical trials.
Integrated Services to Meet Drug Development Needs
Expertise
Oncotech has world-class scientists and pathologists, NIH trained
practicing physicians, information technology experts and clinical
trial specialists, housed in one facility. Click here
for more information about our scientific staff.
Characterized Cancer Specimens
Oncotech's viable cancer explant archive contains greater than
37,000 cryopreserved cancer specimens (99 tumor types
represented) with matching paraffin blocks linked to
drug resistance data and clinical biomarker results. Oncotech also
maintains over 138,000 paraffin-embedded tumor specimens linked to drug
resistance data and clinical biomarker results.
Advanced Technology
Oncotech's Drug Development Group offers high quality laboratory testing,
performed under the highest quality standards.
Bioinformatic Database
Oncotech uses an integrated systems approach to data generation and
management. Oncotech's computer database contains information on more
than 80,000 human tumors, including the results of drug resistance
testing, prognostic and predictive marker assays, and pathology
testing.
Oncotech can directly affect all phases of the advanced drug development process
Pre-Clinical and Clinical Studies
- Drug candidate and compound validation
- Drug target identification and characterization
- Indication-specific drug efficacy characterization
- Drug activity comparison to conventional agents
- Pre-screening of patients for clinical trials
- Surrogate efficacy assay development and monitoring in clinical trials
- Develop and commercialization of theragnostic assays
- Drug synergy studies, treatment failure analysis and tumor marker surveys
Reducing the Costs for Success
Oncotech's integrated drug development services provides information
and insight to enable innovative pharmaceutical companies to conduct
smaller, more focused and successful clinical trials, thereby reducing
the costs and time required to gain FDA approval and move product to
market.
Contact Oncotech's Pharmaceutical Services at (800) 576-6326 for a
consultation, or e-mail inquiries to
drugdevelopment@oncotech.com.
